1 |
Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials[J]. Am J Transplant, 2018, 18(2): 293-307.
|
2 |
Stratta RJ, Rohr MS, Sundberg AK, et al. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality[J]. Ann Surg, 2006, 243(5): 594-601; discussion 601-603.
|
3 |
蔡治涛. 亲属活体供肾移植与尸体供肾移植术后临床疗效比较与分析[D]. 武汉:华中科技大学,2008.
|
4 |
Zhang X, Lyu J, Yu X, et al. Comparison of graft outcome between donation after circulatory death and living-donor kidney transplantation[J]. Transplant Proc, 2020, 52(1): 111-118.
|
5 |
Mandal AK, Snyder JJ, Gilbertson DT, et al. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation?[J]. Transplantation, 2003, 75(4): 494-500.
|
6 |
Xiong Y, Jiang J, Zhang H, et al. Higher renal allograft function in deceased-donor kidney transplantation rather than of living-related kidney transplantation[J]. Transplant Proc, 2018, 50(8): 2412-2415.
|
7 |
Solà R, Vela E, Cleries M, et al. Living donor kidney transplantation in catalonia: comparison with cadaveric kidney donors[J]. Transplant Proc, 2007, 39(7): 2208-2209.
|
8 |
García-Maset R, Perich LG, Vallespin EV, et al. Living donor renal transplantation in catalonia: overall results and comparison of survival with cadaveric donor renal transplantation[J]. Transplant Proc, 2005, 37(9): 3682-3683.
|
9 |
中华医学会器官移植学分会. 肾移植排斥反应临床诊疗技术规范(2019版)[J]. 器官移植,2019, 10(5): 505-512.
|
10 |
中华医学会器官移植学分会. 肾移植术后移植物功能延迟恢复诊疗技术规范(2019版)[J]. 器官移植,2019, 10(5): 521-525.
|
11 |
中华医学会器官移植学分会. 器官移植免疫抑制剂临床应用技术规范(2019版)[J]. 器官移植,2019, 10(3): 213-226.
|
12 |
邓聪,孙卫民,林梅双,等. 肾移植术后肺部感染患者病原体及危险因素分析[J]. 河北医学,2021, 27(2): 279-283.
|
13 |
刘炎忠,柏宏伟,石炳毅,等. 老年肾移植受者肺部感染的危险因素分析[J]. 中华器官移植杂志,2020, 41(4): 247-251.
|
14 |
Guirado L, Vela E, Clèries M, et al. [Why renal transplant from living donors gives better results than cadaver renal transplant][J]. Nefrologia, 2008, 28(2): 159-167.
|
15 |
Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors[J]. Transplantation, 2002, 74(9): 1281-1286.
|
16 |
Hosgood SA, Yang B, Bagul A, et al. A comparison of hypothermic machine perfusion versus static cold storage in an experimental model of renal ischemia reperfusion injury[J]. Transplantation, 2010, 89(7): 830-837.
|
17 |
Lindell SL, Muir H, Brassil J, et al. Hypothermic machine perfusion preservation of the DCD kidney: machine effects[J]. J Transplant, 2013: 802618.
|
18 |
Kinsey GR, Huang L, Vergis AL, et al. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney[J]. Kidney Int, 2010, 77(9): 771-780.
|
19 |
El-Achkar TM. Modulation of apoptosis by ischemic preconditioning: an emerging role for miR-21[J]. Kidney Int, 2012, 82(11): 1149-1151.
|
20 |
赵鸽,陈正春,申新,等. 瑞芬太尼预处理对大鼠肝脏缺血再灌注损伤的影响及机制[J]. 南方医科大学学报,2011, 31(12): 2016-2020.
|